Expression of the anaphylatoxin C5a receptor in non-myeloid cells

Molecular Immunology

Volumn 36, Issue 13-14, 1999, Pages 877-884

  Zwirner, J ^a   Fayyazi, A ^a   Gotze O ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Anaphylatoxin; C5a receptor; Complement; Immunohistochemistry; Monoclonal antibody

Indexed keywords

ANAPHYLATOXIN; COMPLEMENT COMPONENT C5A RECEPTOR; MONOCLONAL ANTIBODY;

ANIMAL CELL; BLOOD VESSEL PERMEABILITY; BONE MARROW CELL; COMPLEMENT ACTIVATION; CONFERENCE PAPER; DEGRANULATION; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR AFFINITY; SMOOTH MUSCLE CONTRACTION;

ANTIGENS, CD; CELLS, CULTURED; COMPLEMENT C5A; GENE EXPRESSION; HUMANS; INTESTINES; KIDNEY; LIVER; LUNG; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, COMPLEMENT; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 0033370490     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(99)00109-1     Document Type: Conference Paper

References (50)

1. Boulay F., Mery L., Tardif M., Brouchon L., Vignais P. Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells. Biochemistry. 30:1991;2993-2999.
2. Braun M., Davis A.E. III. Cultured human mesangial cells express the C5a receptor. J. Immunol. 54:1998;1542-1549.
3. Burg M., Martin U., Rheinheimer C., Kohl J., Bautsch W., Bottger E.C., Klos A. IFN-gamma up-regulates the human C5a receptor (CD88) in myeloblastic U937 cells and related cell lines. J. Immunol. 155:1995;4419-4426.
4. Cavaillon J.M., Fitting C., Haeffner-Cavaillon N. Recombinant C5a enhaces interleukin 1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages. Eur. J. Immunol. 20:1990;253-257.
5. Chenoweth D.E., Hugli T.E. Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. USA. 75:1978;3943-3947.
6. DeMartino J.A., Van Riper G., Siciliano S.J., Molineaux C.J., Konteatis Z.D., Rosen H., Springer M.S. The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs. J. Biol. Chem. 269:1994;14,446-14,450.
7. DeMartino J.A., Konteatis Z., Siciliano S.J., Van Riper G., Underwood D.J., Fischer P.A., Springer M.S. Arginine 206 of the C5a receptor is critical for ligand recognition and receptor activation by C-terminal hexapeptide analogs. J. Biol. Chem. 270:1995;15,966-15,969.
8. Ember J.A., Sanderson S.D., Hugli T.E., Morgan E.L. Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. Am. J. Pathol. 144:1994;393-403.
9. Farkas I., Baranyi L., Takahashi M., Fukuda A., Liposits Z., Yamamoto T., Odada H. A neuronal C5a receptor and an associated apoptotic signal transduction pathway. J. Physiol. 507:1998;679-687.
10. Fayyazi A., Sandau R., Duong L.Q., Götze O., Radzun H.J., Schweyer S., Soruri A., Zwirner J. C5a receptor and interleukin-6 are expressed in tissue macrophages and stimulated keratinocytes but not in pulmonary and intestinal epithelial cells. Am. J. Pathol. 154:1999;495-501.
11. Fayyazi, A., Scheel, O., Werfel, T., Schweyer, S., Oppermann, M., Götze, O., Radzun, H.J., Zwirner, J., 1999b. The human C5a receptor is expressed in normal renal proximal tubular but not in normal pulmonary or hepatic epithelial cells. Immunology (in press).
12. Floreani A.A., Heires A.J., Welniak L.A., Miller-Lindholm A., Clark-Pierce L., Rennard S.I., Morgan E.L., Sanderson S.D. Expression of receptors for C5a anaphylatoxin (CD88) on human bronchial epithelial cells: enhancement of C5a-mediated release of IL-8 upon exposure to cigarette smoke. J. Immunol. 160:1998;5073-5081.
13. Foreman K.E., Vaporciyan A.A., Bonish B.K., Jones M.L., Johnson K.J., Glovsky M.M., Eddy S.M., Ward P.A. C5a-induced expression of P-selectin in endothelial cells. J. Clin. Invest. 94:1994;1147-1155.
14. Freeman G.J., Cardoso A.A., Boussiotis V.A., Anumanthan A., Groves R.W., Kupper T.S., Clark E.A., Nadler L.M. The BB1 monoclonal antibody recognizes both cell surface CD74 (MHC class II-associated invariant chain) as well as B7-1 (CD80), resolving the question regarding a third CD28/CTLA-4 counterreceptor. J. Immunol. 161:1998;2708-2715.
15. Gasque P., Chan P., Fontaine M., Ischenko A., Lamacz M., Götze O., Morgan B.P. Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes. J. Immunol. 155:1995;4882-4889.
16. Gasque P., Singhrao S.K., Neal J.W., Gotze O., Morgan B.P. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am. J. Pathol. 150:1997;31-41.
17. Gerard N.P., Hodges M.K., Drazen J.M., Weller P.F., Gerard C. Characterization of a receptor for C5a anaphylatoxin on human eosinophils. J. Biol. Chem. 264:1989;1760-1766.
18. Gerard N.P., Gerard C. The chemotactic receptor for human C5a anaphylatoxin. Nature. 349:1991;614-617.
19. Gerritsma J.S., Hiemstra P.S., Gerritsen A.F., Prodjosudjadi W., Verweij C.L., van Es L.A., Daha M.R. Regulation and production of IL-8 by human proximal tubular epithelial cells in vitro. Clin. Exp. Immunol. 103:1996;289-294.
20. Gerritsma J.S., van Kooten C., Gerritsen A.F., Mommaas A.M., van Es L.A., Daha M.R. Production of inflammatory mediators and cytokine responsiveness of an SV40-transformed human proximal tubular epithelial cell line. Exp. Nephrol. 6:1998;208-216.
21. Goldstein I.M. Complement-biologically active products. Gallin J.I., Goldstein I.M., Snyderman R. Inflammation: Basic Principles and Clinical Correlates. 2nd ed. 1992;63-85 Raven Press, New York.
22. Haviland D.L., McCoy R.L., Whitehead W.T., Akama H., Molmenti E.P., Brown A., Haviland J.C., Parks W.C., Perlmutter D.H., Westel R.A. Cellular expression of the C5a anaphylatoxin receptor (C5aR): Demonstration of C5aR on nonmyeloid cells of the liver and lung. J. Immunol. 154:1995;1861-1868.
23. Ikeda K., Nagasawa K., Horiuchi T., Tsuru T., Nishizaka H., Niho Y. C5a induces tissue factor activity on endothelial cell. Thromb. Haemost. 77:1997;394-398.
24. Johnson R.J. Involvement of complement in renal disease. Curr. Opin. Nephrol. Hypertens. 6:1997;120-126.
25. Köhl J., Bitter-Suermann D. Anaphylatoxins. Whaley K., Loos M., Weiler J.M. Complement in Health and Disease. 1993;299-324 Kluwer Academic Publishers, Dorbrecht.
26. Kurimoto Y., de Weck A.L., Dahinden C.A. Interleukin 3-dependent mediator release in basophils triggered by C5a. J. Exp. Med. 170:1989;467-479.
27. Lacy M., Jones J., Whittemore S.R., Haviland D.L., Wetsel R.A., Barnum S.R. Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia. J. Neuroimmunol. 61:1995;71-78.
28. Lundberg C., Marceau F., Huey R., Hugli T.E. Anyphylatoxin C5a fails to promote prostacyclin release in cultured endothelial cells from human umbilical veins. Immunopharmacology. 12:1996;135-143.
29. Martin U., Bock D., Arseniev L., Tornetta M.A., Ames R.S., Bautsch W., Köhl J., Ganser A., Klos A. The human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytes. J. Exp. Med. 186:1997;199-207.
30. McCoy R., Haviland D.L., Molmenti E.P., Ziambaras T., Wetsel R.A., Perlmutter D.H. N-Formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation. J. Exp. Med. 182:1995;207-213.
31. McLean R.H. Complement and glomerulonephritis - an update. Pediatr. Nephrol. 7:1993;226-232.
32. Montz H., Koch K.C., Ziers R., Götze O. The role of C5a in interleukin-6 production induced by lipopolysaccharide or interleukin-1. Immunology. 74:1991;373-379.
33. Morgan E.L., Ember J.A., Sanderson S.D., Scholz W., Buchner R., Ye R.D., Hugli T.E. Anti-C5a receptor antibodies: characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from predicted amino-terminal of the human C5a receptor. J. Immunol. 151:1993;377-388.
34. Nataf S., Davoust N., Ames R.S., Barnum S.R. Human T cells express the C5a receptor and are chemoattracted to C5a. J. Immunol. 162:1999;4018-4023.
35. 2-terminal domain. J. Immunol. 151:1993;3785-3792.
36. Ottonello L., Corcione A., Tortolina G., Airoldi I., Albesiano E., Favre A., D'Agostino R., Malavasi F., Pistoia V., Dallegri F. rC5a directs the in vitro migration of human memory and naive tonsillar B lymphocytes: implications for B cell trafficking in secondary lymphoid tissues. J. Immunol. 162:1999;6510-6517.
37. Prodjosudjadi W., Gerritsma J.S., Klar-Mohamad N., Gerritsen A.F., Bruijn J.A., Daha M.R., van Es L.A. Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells. Kidney Int. 48:1995;1477-1486.
38. Rothermel E., Zwirner J., Vogt T., Rabini S., Gotze O. Molecular cloning and expression of the functional rat C5a receptor. Mol. Immunol. 34:1997;877-886.
39. Schieferdecker H.L., Rothermel E., Timmermann A., Götze O., Jungermann K. Anaphylatoxin C5a receptor mRNA is strongly expressed in Kupffer and stellate cells and weakly in sinusoidal endothelial cells but not in hepatocytes of normal rat liver. FEBS Lett. 406:1997;305-311.
40. Schieferdecker H.L., Pestel S., Rothermel E., Puschel G.P., Gotze O., Jungermann K. Stimulation by anaphylatoxin C5a of glycogen phosphorylase in rathepatocytes via prostanoid release from hepatic stellate cells but not sinusoidal endothelial cells. FEBS Lett. 434:1998;245-250.
41. Schindler R., Gelfand J.A., Dinarello C.A. Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself. Blood. 76:1990;1631-1638.
42. 2+ release. Lab. Invest. (in press).
43. Siciliano S.J., Rollins T.E., DeMartino J., Konteatis Z., Malkowitz L., Van Riper G., Bondy S., Rosen H., Springer M.S. Two-site binding of C5a to its receptor: an alternative binding paradigm for G-protein coupled receptors. Proc. Natn. Acad. Sci. USA. 91:1994;1214-1219.
44. Stahel P.F., Frei K., Eugster H.P., Fontana A., Hummel K.M., Wetsel R.A., Ames R., Barnum S.R. TNF-α-mediated expression of the receptor for anaphylatoxin C5a (C5aR) on neurons in experimental Listeria meningoencephalitis. J. Immunol. 159:1997;861-869.
45. Werfel T., Oppermann M., Schulze M., Krieger G., Weber M., Götze O. Binding of fluorescein-labeled anaphylatoxin C5a to human peripheral blood, spleen, and bone marrow leukocytes. Blood. 79:1992;151-159.
46. Werfel T., Zwirner J., Oppermann M., Sieber A., Begemann G., Drommer W., Kapp A., Götze O. CD88 antibodies specifically bind to C5aR on dermal CD117+ and CD14+ cells and react with a desmosomal antigen in human skin. J. Immunol. 157:1996;1729-1738.
47. Wilmer W.A., Kaumaya P.T., Ember J.A., Cosio F.G. Receptors for the anaphylatoxin C5a (CD88) on human mesangial cells. J. Immunol. 160:1998;5646-5652.
48. Wittmann M., Zwirner J., Larsson V.-A., Kirchhoff K., Begemann G., Kapp A., Götze O., Werfel T. C5a suppresses the production of IL-12 by human monocytes. J. Immunol. 162:1999;6763-6769.
49. Zahn S., Zwirner J., Spengler H.-P., Götze O. Chemoattractant receptors for interleukin-8 and C5a: expression on peripheral blood leukocytes and differential regulation on HL-60 and AML-193 cells by vitamin D3 and all-trans retinoic acid. Eur. J. Immunol. 27:1997;935-941.
50. Zwirner J., Götze O., Begemann G., Kapp A., Kirchhoff K., Werfel T. Evaluation of C3a receptor expression on human leukocytes by the use of novel monoclonal antibodies. Immunology. 97:1999;166-172.